Biotech

All Articles

Gilead pays J&ampJ $320M to leave licensing deal for seladelpar

.Along With Gilead Sciences on the verge of an FDA choice for its own liver condition medicine selad...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks can view the companies putting together tents at basecamp respo...

Entero giving up team, vacating office and also stopping briefly R&ampD

.Mattress Liquidators has actually switched Entero Therapeutics white as a piece. The creditor purch...

Exelixis goes down ADC after determining it is actually no suit for Tivdak

.Exelixis is actually surrendering on its own tissue factor (TF)- targeting antibody-drug conjugate ...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.3 weeks after Roche's Genentech device ignored an SHP2 prevention treaty, Relay Therapeutics has ac...

Stoke's Dravet disorder med launched of partial medical grip

.Stoke Therapies' Dravet disorder medication has been actually freed from a predisposed hold, removi...

Fierce Biotech's Gabrielle Masson offers Brutal 15 at NYSE

.Ferocious Biotech Partner Publisher Gabrielle Masson showed the 2024 lesson of Intense 15 victors o...

Daiichi spends Merck $170M to create lung cancer T-cell engager treaty

.Merck &amp Co. has rapidly recovered a few of the prices of its own Weapon Therapeutics buyout, pul...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin conducted a springtime clean of its own pipe in April, the business has actually det...

Eisai plants molecular glue SEED with $1.5 B biobucks handle

.Significant Pharmas remain caught to the tip of molecular adhesive degraders. The most up to date f...